Global Dialysis - France and Germany suspend approval for pioglitazone due to bladder cancer risk question; other countries not yet.

France and Germany suspend approval for pioglitazone due to bladder cancer risk question; other countries not yet.

Reuters: Other European countries are holding fire on Takeda Pharmaceutical's drug Actos, after France and Germany said they were suspending the diabetes drug because of fears over bladder cancer.

...